Efficacy of prophylactic Immucothel® in patients pretreated with conventional drugs to prevent recurrence of superficial bladder carcinoma

European Urology

Volumn 37, Issue SUPPL. 3, 2000, Pages 50-53

  Echarti, C ^a,b   Jurincic Winkler, C D ^a   Klippel, K F ^a  

^a Academic Hospital   (Germany)

^b NONE   (Germany)

Author keywords

Immucothel ; Prophylaxis of recurrence; Recurrence free interval; Superficial urinary bladder carcinoma

Indexed keywords

BCG VACCINE; DOXORUBICIN; KEYHOLE LIMPET HEMOCYANIN; MITOMYCIN C;

ADULT; AGED; BLADDER CARCINOMA; BLADDER DISEASE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CYSTITIS; DRUG EFFICACY; FEMALE; HEMORRHAGIC CYSTITIS; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; TUBERCULOSIS;

EID: 0034061940     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052393     Document Type: Conference Paper

References (16)